Results 21 to 30 of about 2,468,898 (371)

Silicon substituted hydroxyapatite/VEGF scaffolds stimulate bone regeneration in osteoporotic sheep [PDF]

open access: yesActa Biomaterialia 101, 544-553 (2019), 2021
Silicon-substituted hydroxyapatite (SiHA) macroporous scaffolds have been prepared by robocasting. In order to optimize their bone regeneration properties, we have manufactured these scaffolds presenting different microstructures: nanocrystalline and crystalline. Moreover, their surfaces have been decorated with vascular endothelial growth factor (VEGF)
arxiv   +1 more source

The Role of VEGF and VEGF Receptors in Carcinogenesis [PDF]

open access: yesJournal of Carcinogenesis & Mutagenesis, 2012
The vascular endothelial growth factor (VEGF) family and its associated cognate receptors are critical components of angiogenesis, the process of new blood vessel formation. Under normal conditions, angiogenesis supports organism development and tissue homeostasis in a tightly controlled fashion.
Kendall S. Frazier, Kevin French
openaire   +2 more sources

Synergistic effect of Si-hydroxyapatite coating and VEGF adsorption on Ti6Al4V-ELI scaffolds for bone regeneration in an osteoporotic bone environment [PDF]

open access: yesActa Biomaterialia. 83, 456-466 (2018), 2021
The osteogenic and angiogenic responses to metal macroporous scaffolds coated with silicon substituted hydroxyapatite (SiHA) and decorated with vascular endothelial growth factor (VEGF) have been evaluated in vitro and in vivo. Ti6Al4V-ELI scaffolds were prepared by electron beam melting and subsequently coated with Ca10(PO4)5.6(SiO4)0.4(OH)1.6 ...
arxiv   +1 more source

VEGF and its receptors - formation, structure, and role in the organism

open access: yesJournal of Education, Health and Sport, 2023
Creating vessels is essential for the development of every organism and the course of repair processes. Under physiological conditions, angiogenesis is a transient and tightly regulated process.
Krzysztof Olczyk   +3 more
doaj   +1 more source

The immunohistochemical landscape of the VEGF family and its receptors in glioblastomas

open access: yesSurgical and Experimental Pathology, 2020
Background Angiogenesis is one of the hallmarks of cancer. This complex mechanism of tumor progression provides tumors cells with essential nutrients. There have been a limited number of investigations of markers of angiogenesis in Glioblastomas (GBMs ...
Luiz Victor Maia Loureiro   +5 more
doaj   +1 more source

Vascular endothelial‐cadherin as a marker of endothelial injury in preclinical Alzheimer disease

open access: yesAnnals of Clinical and Translational Neurology, Volume 9, Issue 12, Page 1926-1940, December 2022., 2022
Abstract Objective Endothelial dysfunction is an early and prevalent pathology in Alzheimer disease (AD). We here investigate the value of vascular endothelial‐cadherin (VEC) as a cerebrospinal fluid (CSF) marker of endothelial injury in preclinical AD.
Rawan Tarawneh   +5 more
wiley   +1 more source

Mechanism of selective VEGF-A binding by neuropilin-1 reveals a basis for specific ligand inhibition. [PDF]

open access: yesPLoS ONE, 2012
Neuropilin (Nrp) receptors function as essential cell surface receptors for the Vascular Endothelial Growth Factor (VEGF) family of proangiogenic cytokines and the semaphorin 3 (Sema3) family of axon guidance molecules. There are two Nrp homologues, Nrp1
Matthew W Parker   +3 more
doaj   +1 more source

Aflibercept—a Decoy VEGF Receptor [PDF]

open access: yesCurrent Oncology Reports, 2014
Aflibercept (known as ziv-aflibercept in the USA and sold under the trade name Zaltrap®) is a human recombinant fusion protein with antiangiogenic effects that functions as a decoy receptor to bind vascular endothelial growth factors A and B and placental growth factor.
Kristen K. Ciombor, Jordan Berlin
openaire   +3 more sources

Functional VEGF and VEGF receptors are expressed in human medulloblastomas [PDF]

open access: yesNeuro-Oncology, 2007
Vascular endothelial growth factor (VEGF) is one of the key regulators of tumor neoangiogenesis. It acts through two types of high-affinity tyrosine kinase receptors (VEGF receptor-1 [VEGFR-1]/fms-related tyrosine kinase 1 [Flt-1] and VEGFR-2/kinase domain receptor [KDR]) expressed on endothelial cells.
SLONGO, MARA LILIANA   +8 more
openaire   +4 more sources

Vascular endothelial growth factor and its receptors regulation in gestational diabetes mellitus and eclampsia

open access: yesJournal of Translational Medicine, 2022
Background An imbalance in the expression of vascular endothelial growth factor (VEGF) and its receptor (VEGF-R) during pregnancy plays an important role in the pathogenesis of gestational diabetes mellitus (GDM) and eclampsia.
Alayi Bolatai, Yujing He, Na Wu
doaj   +1 more source

Home - About - Disclaimer - Privacy